87 related articles for article (PubMed ID: 7842297)
1. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.
Morris CM; Kerwin JM; Edwardson JA
Neurodegeneration; 1994 Dec; 3(4):267-75. PubMed ID: 7842297
[TBL] [Abstract][Full Text] [Related]
2. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
3. [Microtubule-associated protein30 (MAP30) and ubiquitin detected in neurofibrillary tangles of Alzheimer's disease brains].
Liu Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):11-3. PubMed ID: 10681783
[TBL] [Abstract][Full Text] [Related]
4. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.
Quintana C; Bellefqih S; Laval JY; Guerquin-Kern JL; Wu TD; Avila J; Ferrer I; Arranz R; Patiño C
J Struct Biol; 2006 Jan; 153(1):42-54. PubMed ID: 16364657
[TBL] [Abstract][Full Text] [Related]
5. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease.
Geddes JW; Lundgren K; Kim YK
J Neurosci Res; 1991 Sep; 30(1):183-91. PubMed ID: 1795403
[TBL] [Abstract][Full Text] [Related]
6. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease.
Ikonomovic MD; Sheffield R; Armstrong DM
Hippocampus; 1995; 5(5):469-86. PubMed ID: 8773259
[TBL] [Abstract][Full Text] [Related]
7. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
8. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
Sudo S; Shiozawa M; Cairns NJ; Wada Y
J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
[TBL] [Abstract][Full Text] [Related]
9. Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients.
Qin S; Hu XY; Xu H; Zhou JN
Acta Neuropathol; 2004 Mar; 107(3):209-15. PubMed ID: 14673601
[TBL] [Abstract][Full Text] [Related]
10. Iron histochemistry of the substantia nigra in Parkinson's disease.
Morris CM; Edwardson JA
Neurodegeneration; 1994 Dec; 3(4):277-82. PubMed ID: 7842298
[TBL] [Abstract][Full Text] [Related]
11. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.
Simic G; Lucassen PJ; Krsnik Z; Kruslin B; Kostovic I; Winblad B; Bogdanovi
Exp Neurol; 2000 Sep; 165(1):12-26. PubMed ID: 10964481
[TBL] [Abstract][Full Text] [Related]
12. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease.
Ryoo HL; Joyce JN
J Comp Neurol; 1994 Oct; 348(1):94-110. PubMed ID: 7814686
[TBL] [Abstract][Full Text] [Related]
13. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
[TBL] [Abstract][Full Text] [Related]
14. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
Lovell MA; Ehmann WD; Markesbery WR
Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
[TBL] [Abstract][Full Text] [Related]
15. Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.
Marcus DL; Strafaci JA; Freedman ML
Med Sci Monit; 2006 Jan; 12(1):BR8-14. PubMed ID: 16369462
[TBL] [Abstract][Full Text] [Related]
16. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
[TBL] [Abstract][Full Text] [Related]
17. In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study.
Frisoni GB; Sabattoli F; Lee AD; Dutton RA; Toga AW; Thompson PM
Neuroimage; 2006 Aug; 32(1):104-10. PubMed ID: 16631382
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
19. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
20. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
